Copenhagen, DENMARK — Obesity drug giant Novo Nordisk said Thursday that the rampant growth of the U.S.' compounded drug industry was hurting Wegovy sales, and warned it was considering legal ...

Novo Nordisk is cutting the price of its weight-loss drug Wegovy to $499 per month for cash-paying customers who buy through its NovoCare Pharmacy. The discounted price is aimed at uninsured ...

In another example of the volatility facing developers of obesity drugs, Veru saw its share price cut nearly in half – despite reporting ostensibly positive data for a drug candidate. Veru's ...

Semaglutide is the active ingredient in Wegovy It is also the main component of Ozempic Semaglutide is known to increase the risk of hair loss Semaglutide, the main ingredient in Ozempic and ...

Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to patients paying cash, as it grapples with shifts to the competitive ...

Yet another drink is being touted on TikTok as “nature’s Ozempic.” Yerba mate has so many people saying it’s helped them lose weight that it’s kind of hard to ignore—some are even ...

Wegovy (semaglutide) and Mounjaro (tirzepatide) are brand-name injections. Wegovy is prescribed for weight loss and to lower cardiovascular risks. Mounjaro is approved for type 2 diabetes, and ...

March 24 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Monday all eligible cash-paying customers in the United States can buy its weight-loss drug Wegovy at a discounted price of $499 ...

The heavy selling pressure might have exhausted for Veru (VERU) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in ...